240 related articles for article (PubMed ID: 32362618)
21. Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study.
Kuerbitz SJ; Civin CI; Krischer JP; Ravindranath Y; Steuber CP; Weinstein HJ; Winick N; Ragab AH; Gresik MV; Crist WM
J Clin Oncol; 1992 Sep; 10(9):1419-29. PubMed ID: 1517785
[TBL] [Abstract][Full Text] [Related]
22. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse.
Pui CH; Raimondi SC; Head DR; Schell MJ; Rivera GK; Mirro J; Crist WM; Behm FG
Blood; 1991 Sep; 78(5):1327-37. PubMed ID: 1878594
[TBL] [Abstract][Full Text] [Related]
23. CD7 expression in acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
[TBL] [Abstract][Full Text] [Related]
24. Frequency and Prognostic Impact of Aberrant Antigens Expression among Egyptian Adult Acute Leukemia.
Kaheled O; Aref S; El Menshawy N; Aref M; Ayed M
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4301-4307. PubMed ID: 38156867
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
26. [The features and significance of immunophenotyping in adult acute leukemia].
Pei MF; Zhang GS; Xiao L
Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):262-4. PubMed ID: 12212161
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
28. The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0.
Suzuki R; Ohtake S; Takeuchi J; Nagai M; Kodera Y; Hamaguchi M; Miyawaki S; Karasuno T; Shimodaira S; Ohno R; Nakamura S; Naoe T
Int J Hematol; 2010 Mar; 91(2):303-9. PubMed ID: 20111912
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance.
Drexler HG; Thiel E; Ludwig WD
Leukemia; 1993 Apr; 7(4):489-98. PubMed ID: 7681917
[TBL] [Abstract][Full Text] [Related]
30. [Immunophenotypes, cytogenetics and clinical features of 192 patients with acute myeloid leukemia].
Tong HX; Wang HH; Zhang JH; Liu ZG; Zheng YC; Wang YX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1174-8. PubMed ID: 19840445
[TBL] [Abstract][Full Text] [Related]
31. [Expression of Th17 and IL-23 in Peripheral Blood and Their Relationship with Immunophenotype in Patients with Acute Myeloid Leukemia].
Peng ZY; Yang CX; San JH; Li QQ; Zhang MM; Shi B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1056-1062. PubMed ID: 35981362
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic, cytogenetic and clinical features of 192 AML patients in China.
Tong H; Lu C; Zhang J; Liu Z; Ma Y
Clin Exp Med; 2009 Jun; 9(2):149-55. PubMed ID: 19205620
[TBL] [Abstract][Full Text] [Related]
33. Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML.
Sperling C; Büchner T; Creutzig U; Ritter J; Harbott J; Fonatsch C; Sauerland C; Mielcarek M; Maschmeyer G; Löffler H
Leuk Lymphoma; 1995 May; 17(5-6):417-26. PubMed ID: 7549832
[TBL] [Abstract][Full Text] [Related]
34. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
[TBL] [Abstract][Full Text] [Related]
35. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
Liu YR; Zhu HH; Ruan GR; Qin YZ; Shi HX; Lai YY; Chang Y; Wang YZ; Lu D; Hao L; Li JL; Li LD; Jiang B; Huang XJ
Leuk Res; 2013 Jul; 37(7):737-41. PubMed ID: 23601747
[TBL] [Abstract][Full Text] [Related]
36. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
[TBL] [Abstract][Full Text] [Related]
37. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.
Karandikar NJ; Aquino DB; McKenna RW; Kroft SH
Am J Clin Pathol; 2001 Aug; 116(2):204-10. PubMed ID: 11488066
[TBL] [Abstract][Full Text] [Related]
38. [Cellular immunophenotypes in 97 adults with acute leukemia].
Piedras J; López-Karpovitch X; Cárdenas MR
Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
[TBL] [Abstract][Full Text] [Related]
39. Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia.
Ouyang G; Xu Z; Jiang D; Zhu H; Wang Y; Wu W; Sun Y; Sheng L; Xu K; Lou Y; Mu Q; Zhang Y; Wu N; Cheng J; Duan S
J Int Med Res; 2019 Apr; 47(4):1483-1492. PubMed ID: 30614357
[TBL] [Abstract][Full Text] [Related]
40. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
